80
Views
3
CrossRef citations to date
0
Altmetric
Review

Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical review

Pages 1051-1059 | Published online: 01 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Monika Tomaszewska-Kiecana, Anna Dryja, Martin Ullmann, Corinne Petit-Frere, Andras Illes, Christos Dagres & Joëlle Monnet. (2023) Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Expert Review of Clinical Immunology 19:4, pages 447-455.
Read now

Articles from other publishers (2)

Nicolino Ruperto, Hermine I Brunner, Athimalaipet V Ramanan, Gerd Horneff, Rubén Cuttica, Michael Henrickson, Jordi Anton, Alina Lucica Boteanu, Inmaculada Calvo Penades, Kirsten Minden, Heinrike Schmeling, Markus Hufnagel, Jennifer E Weiss, Manuela Pardeo, Kabita Nanda, Johannes Roth, Nadina  Rubio-Pérez, Joy C Hsu, Sunethra Wimalasundera, Chris Wells, Kamal  Bharucha, Wendy Douglass, Min Bao, Navita L Mallalieu, Alberto Martini, Daniel Lovell & Fabrizio De Benedetti. (2021) Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis. Rheumatology 60:10, pages 4568-4580.
Crossref
Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen Hall, Piotr Leszczynski, Daniel Feldman, Madura J Rangaraj, Georgia Roane, Charles Ludivico, Min Bao, Lucy Rowell, Claire Davies & Eduardo F Mysler. (2016) Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Annals of the Rheumatic Diseases 75:1, pages 68-74.
Crossref